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Narrow-Band UVB Induces More Carcinogenic
Skin Tumors than Broad-Band UVB through the
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Chikako Nishigori1
Phototherapy with narrow-band UVB (NB-UVB), with a peak exclusively at 311 nm wavelength, has been found
to be more effective in treating a variety of skin diseases than conventional broad-band UVB (BB-UVB). To
assess the difference in carcinogenic activity between NB-UVB and BB-UVB, we investigated skin tumor
formation by irradiating albino hairless, Ogg1 knockout mice and C57BL/6J wild counterparts with these two UV
sources. We found that the ratio of malignant skin tumors induced by NB-UVB was significantly higher than that
induced by BB-UVB. There was no significant difference in carcinogenicity of skin tumor induced by NB-UVB
between Ogg1 knockout and wild-type mice. To investigate the possible cause of different carcinogenic activity
by the different UV sources, we examined three types of DNA damage: cyclobutane pyrimidine dimer (CPD),
(6-4) photoproduct, and 8-oxoguanine (8-oxoG) induced by each UV source. We found that CPD formation
following a minimum erythema dose (MED) by NB-UVB was significantly higher than that following 1 MED by
BB-UVB, whereas the formation of (6-4) photoproducts and 8-oxoG following BB-UVB was significantly higher
than those following NB-UVB exposure. These results suggest that CPD formation is closely related to the
higher carcinogenic characteristics of NB-UVB. JID JOURNAL CLUB ARTICLE: For questions, answers and open
discussion about this article please go to htt://network.nature.com/
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INTRODUCTION
Phototherapy, particularly UVB treatment, is widely used to
effectively treat various skin diseases. Narrow-band UVB (NB-
UVB) treatment, with a peak wavelength of 311 nm, has been
shown to be effective for a variety of skin diseases such as
psoriasis vulgaris, vitiligo vulgaris, and atopic dermatitis. Some
reports indicate that NB-UVB is more therapeutic than broad-
band UVB (BB-UVB), which has a wavelength range between
280 and 320 nm (van Weelden et al., 1988; Coven et al.,
1997; Walters et al., 1999; Gathers et al., 2002; Samson
Yashar et al., 2003) (Figure 1a). However, the effectiveness of
NB-UVB needs to be considered along with its adverse effects,
mainly skin carcinogenesis, since UVB causes the develop-
ment of skin cancers in humans and in other animals (Kraemer,
1997). There are several reports about skin carcinogenesis
following NB-UVB therapy compared with BB-UVB, showing
that NB-UVB is more carcinogenic than BB-UVB (van
Weelden et al., 1988; Flindt-Hansen et al., 1991; Wulf
et al., 1994; Gibbs et al., 1995), which is now considered to
be tentative consensus (Young, 1995; el-Ghorr and Norval,
1997). In this study, we performed a comparative study of skin
tumor formation following exposure to NB-UVB or BB-UVB,
using different strains of mice. We also investigated the
specific mechanism involved in skin carcinogenesis caused by
NB-UVB or BB-UVB, particularly focusing on the types of UV-
induced DNA damage such as cyclobutane pyrimidine dimer
(CPD), (6-4) photoproduct, and oxidative DNA damage.
Reactive oxygen species, which are generated endogen-
ously by cellular oxygen metabolism or exogenously by UV,
environmental mutagens, produce various types of DNA
damage (Hattori-Nakakuki et al., 1994; Aburatani et al.,
1997). Among many oxidative DNA base modifications,
8-oxoguanine (8-oxoG) can pair with adenine as well as
cytosine during DNA replication, which results in GC-TA
transversion mutations (Kasai et al., 1991; Maki and
Sekiguchi, 1992). 8-OxoG is one type of oxidative DNA
damage that can result in stable mutations. In mammalian
cells, the Ogg1 gene encodes 8-oxoG-DNA glycosylase, a
repair enzyme, which removes the oxidized base from DNA.
As we have reported, 8-oxoG formation plays an important
role in the development of skin cancers following BB-UVB
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minimal erythema dose
exposure (Kunisada et al., 2005). In this study, we also
studied whether oxidative DNA damage involves in the
carcinogenesis by NB-UVB using Ogg1 knockout mice.
Overall, we found that NB-UVB induces more malignant
skin tumors through the formation of CPD rather than (6-4)
photoproduct or 8-oxoG. This finding provides early evi-
dence of the types of DNA damage closely related to UV
carcinogenesis caused by NB-UVB or BB-UVB, which have
different photocarcinogenic features.
RESULTS
Comparative study: difference of skin carcinogenicity between
NB-UVB and BB-UVB
We compared the formation of skin tumors following chronic
exposure to NB-UVB or BB-UVB (Figure 1a) using albino
hairless, hairy C57BL/6J, and Ogg1 knockout mice (C57BL
background), with minimum erythema dose (MED) doses of
each type of UVB. MED in albino mice induced by BB-UVB
and NB-UVB was 170 and 370 mJ/cm2, respectively (Figure
1b). MED in C57BL/6J induced by BB-UVB and NB-UVB was
250 and 850 mJ/cm2, respectively. We performed histological
analyses of all skin tumors that developed. The total numbers
of skin tumors induced by NB-UVB are not significantly
different from that by BB-UVB (albino hairless mice: P¼0.20;
C57BL/6J mice: P¼ 0.43). However, the ratios of malignant
skin tumors produced by NB-UVB were 80.0 and 91.6% in
hairless mice and in C57BL/6J mice, respectively. That is a
significantly higher rate than that produced by BB-UVB, in
which 61.2 and 50.0% were malignant tumors in hairless mice
and in C57BL/6J mice, respectively (albino hairless mice:
P¼0.026; C57BL/6J mice: P¼ 0.022) (Tables 1 and 2 and
Figure 2a and b). Since we previously reported the involve-
ment of oxidative stress in photocarcinogenesis by comparing
the BB-UVB induced formation of skin tumors between wild-
type and Ogg1 knockout mice (Kunisada et al., 2005), we then
also evaluated the involvement of oxidative DNA damage in
the development of skin tumors following chronic NB-UVB
exposure. The number of skin tumors and rates of malignant
tumors induced by NB-UVB was not significantly different
irrespective of Ogg1 genotypes (Table 2 and Figure 2b).
Immunohistochemistry: accumulation of DNA damages in the
epidermis following NB-UVB or BB-UVB
We then investigated the relevance of UV-induced DNA
damage, such as CPD, (6-4) photoproduct, and 8-oxoG, for
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Figure 1. Comparison of two UVB sources. (a) Spectra of NB-UVB and
BB-UVB. (b) MED of mice induced by NB-UVB or BB-UVB. The redness of
back skins for albino hairless mice at minimal erythema dose of BB-UVB
and NB-UVB; left three mice: BB-UVB with 170 mJ/cm2; right three mice:
NB-UVB with 370 mJ/cm2.
Table 1. Tumor formation by chronic NB-UVB or BB-UVB irradiation of albino hairless mice
Histological analysis %
Total number of tumors Malignant tumors % Benign tumors %
UVB
source Male Female Total
Mean number
of tumors/
mouse
Squamous
cell
carcinoma Sarcoma Total Papilloma Cyst Total Unidentified1
Narrow
Band
13 (2)2 37 (7) 40 (9) 4.4472.79w 80.0 (32/40)3 0 (0/40) 80.0 (32/40)z 10.0 (4/40) 5.0 (2/40) 15.0 (6/40) 5.0 (2/40)
Broad
Band
6 (2) 43 (6) 49 (8) 6.1375.00w 57.1 (28/49) 4.1 (2/49) 61.2 (30/49)z 36.7 (18/49) 0 (0/49) 36.7 (18/49) 2.0 (1/49)
BB-UVB, broad-band UVB; NB-UVB, narrow-band UVB.
1Unidentified tumors were those which we were not able to make the diagnosis due to the failure of the embedding the specimens.
2The number of skin tumor-bearing mice at the end of the experiment.
3The number of skin tumors/total skin tumors histologically.
wP, not significant.
zPo0.05.
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the different ratio of malignant skin tumors following NB-
UVB or BB-UVB irradiation. We immunohistochemically
quantified the accumulation of those DNA damage in
epidermis and dermis following NB-UVB or BB-UVB
exposure using Image J analysis software. The strong
accumulation of CPD was observed in epidermal cells at
both 3 minutes and 3 hours after NB-UVB or BB-UVB
exposure at similar levels. The lesser amount of immuno-
fluorescent staining was observed in dermis at 3 minutes and
3 hours after NB-UVB or BB-UVB exposure at similar level.
However, a greater amount of immunofluorescent staining
was observed in epidermis at 72 hours after NB-UVB
exposure than after BB-UVB exposure (Po0.0001) (Figure
3a). There was no significant difference in intensity of CPD
irrespective of Ogg1 genotype at any time after NB-UVB or
BB-UVB exposure (data not shown). Conversely, the staining
intensity of (6-4) photoproduct was more significant in both
epidermal and dermal cells at 3 minutes (epidermis:
Po0.0001; dermis: Po0.001, respectively) and 3 hours
(epidermis: Po0.0001; dermis: Po0.05, respectively) after
BB-UVB exposure than after NB-UVB exposure. Staining
signal was low in both epidermal and dermal cells 72 hours
after exposure to either NB-UVB or BB-UVB (Figure 3b).
There was no significant difference in the intensity of (6-4)
photoproduct in epidermal cells irrespective of Ogg1 geno-
type at any time after either NB-UVB or BB-UVB exposure
(data not shown). The accumulation of 8-oxoG was signifi-
cantly strong for epidermal cells 3 hours after BB-UVB
exposure than after NB-UVB exposure in both Ogg1 knockout
mice and wild-type mice (Po0.0001) (Figure 3c). The lesser
amount of immunofluorescent staining was observed in
dermis after 3 and 72 hours after NB-UVB or BB-UVB
exposure with no significance. There was no significant
difference in intensity of 8-oxoG for epidermal cells irrespec-
tive of Ogg1 genotype at any time after NB-UVB exposure.
However, the intensity of 8-oxoG in the epidermis was much
higher in Ogg1 knockout mice than in wild-type mice
72 hours after BB-UVB exposure (Po0.0001) (Figure 3c),
which confirms our previous studies (Kunisada et al., 2005).
Table 2. Tumor formation by chronic NB-UVB irradiation for Ogg1 knockout mice and its wild counterpart in
comparison with that by BB-UVB
Histological analysis %
Total number of tumors Malignant tumors % Benign tumors %
UVB
source
Ogg1
genotype Male Female Total
Mean number
of tumors/mouse
Squamous cell
carcinoma Sarcoma Total Papilloma Total Unidentified1
Narrow
band
Wild 3 (1)2 9 (6) 12 (7) 1.7170.76w 67.7 (8/12)3 25.0 (3/12) 91.6z,* (11/12) 8.3 (1/12) 8.3 (1/12) 0 (0/12)
Knockout 4 (2) 5 (3) 9 (5) 1.8070.84w 66.7 (6/9) 22.2(2/9) 88.9* (8/9) 11.1 (1/9) 11.1 (1/9) 0 (0/9)
Broad
band4
Wild 2 (1) 10 (6) 12 (7) 1.7170.76w,** 41.7 (5/12) 8.3 (1/12) 50.0z,*** (6/12) 41.7 (5/12) 41.7 (5/12) 8.3 (1/12)
Knockout 5 (1) 21 (6) 26 (7) 3.7171.38** 73.1 (19/26) 15.4 (4/26) 88.5*** (23/26) 11.5 (3/26) 11.5 (3/26) 0 (0/16)
BB-UVB, broad-band UVB; NB-UVB, narrow-band UVB.
1Unidentified tumors were those which we were not able to make the diagnosis due to the failure of the embedding the specimens.
2The number of skin tumor-bearing mice at the end of the experiment.
3The number of skin tumors/total skin tumors histologically.
4Broad band UVB data is on previous proof for comparison.
wP, *P, not significant.
zP, ***Po0.05.
**Po0.01.
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Figure 2. Developing skin tumors induced by NB-UVB or BB-UVB.
Representative features of skin tumor formation in (a) hairless mice and in (b)
C57BL/6J mice irradiated with BB-UVB (left four mice), irradiated with
NB-UVB (middle four mice), or Ogg1 knockout mice (right four mice) at
the end of the observation period. Arrows indicate the developing tumors.
(b) C57BL/6J mice irradiated with BB-UVB (left four mice) are on previous
proof for comparison.
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Induction of skin tumors: comparison between NB-UVB and
BB-UVB in Ogg1 wild and knockout mice
Furthermore, we evaluated the skin tumor induction by
chronic NB-UVB or BB-UVB exposure in relevance of
oxidative DNA damage caused by Ogg1 gene disruption.
As shown in Figure 4, in wild-type mice, the first appearance
of tumor was 3 weeks earlier and the time of 100% incidence
was 3 weeks earlier in NB-UVB-irradiated mice than in BB-
UVB-irradiated mice. Tumor induction by NB-UVB was not
significantly different irrespective of Ogg1 genotype.
DISCUSSION
In this study, we showed that chronic exposure of 1 MED of
NB-UVB induces malignant skin tumor in mice at signifi-
cantly higher frequency than that of BB-UVB (albino hairless
mice: P¼ 0.026; C57BL/6J mice: P¼0.022) (Tables 1 and 2
and Figure 2a and b). However, there was no significant
difference in the number of tumors induced by these two UV
sources. To begin this comparative photocarcinogenesis
study between NB-UVB and BB-UVB irradiation on mice,
we had to determine a MED for each strain of mouse. Setting
a MED for NB-UVB or BB-UVB for mice or humans is the
most critical parameter, which might lead to different
outcomes. There are, however, several reports which have
determined the optimal ratios of doses for NB-UVB or BB-
UVB to induce erythema (Wulf et al., 1994; Gibbs et al.,
1995). Originally, the ratio of BB/NB-UVB was calculated by
weighting the spectral irradiance according to the Commis-
sion Internationale de l’Eclairage (CIE) erythema action
spectrum for human skin and was 1:4.2 (Diffey et al.,
1984). After that report, Flindt-Hansen et al. reported that the
ratio of BB/NB-UVB was 1:10.8 and that NB-UVB was more
carcinogenic. The ratio of 1:7.4 and 1:6.3 was also reported
for pigmented hairless and albino hairless mice, respectively
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Figure 3. Kinetic study of epidermal DNA damages after NB-UVB or BB-UVB. Immunostaining of CPD, (6-4) photoproduct, and 8-oxoG in skin
specimens using TDM-2, 64M-1, N45.1, at upper panel of (a–c), respectively, were measured 3 minutes, 3, and 72 hours after NB-UVB or BB-UVB exposure
at the dose of 1 MED along with Ogg1 knockout (KO) mice. The boundary between epidermis and dermis is marked with a broken line. Representive
photomicrographs of at least three independent experiments are shown. Bar¼100 mm. Relative levels of CPD, (6-4) photoproduct, and 8-oxoG in epidermis and
dermis were determined by densitometry in lower panel of (a–c), respectively. *P, **Po0.0001, wPo0.05.
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(Wulf et al., 1994; Gibbs et al., 1995). In contrast, there was
another report that the ratio was 1:2.8 for humans (Hansen
et al., 1994). Our data on the ratio of BB/NB-UVB that
induced a MED was determined in our laboratory, which
simulated the clinical situation for humans (Figure 1b). We
obtained a ratio 1:2.2 for albino hairless mice and 1:3.4 for
C57BL/6J mice. Our measurement of the BB/NB-UVB-
induced MED is similar to a report by Hansen et al., who
speculated that wavelengths below 298 nm or more than
328 nm would be overestimated from the CIE erythema
action. The ratio of malignant tumor induced by NB-UVB
versus that by BB-UVB is higher in C57BL strain (91.6 vs
50.0%) in comparison with that of albino (80.0 vs 61.2%).
The reason for this is possibly because the ratio of NB/BB-
UVB dose irradiated to C57BL is higher (3.4 times) than that
irradiated to albino hairless (2.2 times) if the dose is
determined by MED.
To elucidate the specific mechanism of the higher
carcinogenicity of NB-UVB, we focused on types of DNA
damage induced by UVB, such as CPD, (6-4) photoproduct,
and 8-oxoG. One reason why we focused on the DNA
damage is that there have been reports indicating scale
differences in the action spectrum between the induction of
CPD and (6-4) photoproduct observed in the UVB spectrum
(Mitchell, 1988; Matsunaga et al., 1991; Mizuno et al., 1991).
Another reason is that recently the involvement of reactive
oxygen species in carcinogenesis has been suggested
(Nishigori et al., 2004; Kunisada et al., 2005). Although
UVB has been shown to induce 8-oxoG, we do not know the
action spectrum for 8-oxoG formation. Thus, we consider it is
of importance to see whether NB-UVB is highly productive of
8-oxoG or not. We characterized the accumulation of such
DNA damage caused by NB-UVB or BB-UVB irradiation
using monoclonal antibodies and found that significantly
fewer (6-4) photoproduct were produced by NB-UVB,
whereas BB-UVB produced both CPD and (6-4) photopro-
duct (Figure 3a and b). Moreover, CPD produced by NB-UVB
remained even 72 hours after exposure, which implies that
CPD induced by NB-UVB are more abundant in epidermal
cells, since the repair ability should be the same among the
inbred strain. The mice were irradiated with the UVB dose
inducing 1 MED both for tumor induction and DNA damage
detection, and this dose seems to be too high to accurate
quantification of CPD fluorescence intensity at post-24 hours
UVB exposure. Thus, time course studies were performed to
assess the accumulation of CPD at 3 minutes, 3, and 72 hours
after exposure with precision. These suggest that the more
efficient induction of malignant skin tumors by NB-UVB can
be attributed to CPD formations in epidermal cells rather than
to (6-4) photoproduct formation. There are many reports
indicating the link between CPD induced by UV exposure
and the UV-induced mutations in tumor-related genes such
as p53 (Giglia-Mari and Sarasin, 2003), which explains our
results. Our results showed that the ratio of malignant tumor
formation is higher in NB-UVB-exposed group although the
number of tumors are not different, which might imply the
larger amount of CPD is involved not only in the initiation
phase (the formation of mutation) but also modulate the
immunological response in a way that favors tumor develop-
ment, since there are several pieces of evidence that CPD
play a very important role in UV-induced immune suppres-
sion (Nishigori et al., 1996). This is early evidence that shows
the higher amount of CPD is formed by NB-UVB, which
partly explains the higher incidence of malignant tumors
induced by NB-UVB. Our immunofluorescence time course
studies also revealed that much higher accumulation of (6-4)
photoproduct 3 hours after BB-UVB than that after NB-UVB
exposure result from production of larger amounts of (6-4)
photoproduct by BB-UVB than NB-UVB, since there are
significant differences in the accumulation of (6-4) photo-
product as early as 3 minutes after irradiation.
Recently, the involvement of 8-oxoG has been suggested
in photocarcinogenesis (Basset-Seguin et al., 1994; Agar
et al., 2004; Nishigori et al., 1994, 2004). Indeed, we
previously found that BB-UVB exposure generates 8-oxoG in
epidermal cells and that Ogg1 knockout mice, which are not
able to remove the oxidized base from DNA, are more prone
to having skin cancers following chronic BB-UVB irradiation,
which indicates that oxidative DNA damage caused by BB-
UVB exposure, as well as pyrimidine photoproducts, plays an
important role in the development of skin cancers (Kunisada
et al., 2005). There was no significant difference in either
mean number of tumor nor in ratio of malignant tumor
formation induced by continuous NB-UVB exposure between
Ogg1 knockout mice and wild-type counterpart (Table 2 and
Figure 2b). Although the onset of developing skin tumor with
chronic NB-UVB irradiation in Ogg1 knockout mice appears
earlier than that in wild-type mice, the tumor induction lines
afterwards are similar irrespective of Ogg1 genotype, which
indicates that oxidative DNA damage is rarely responsible for
NB-UVB-induced carcinogenesis. As for the amount of
8-oxoG produced by NB-UVB and BB-UVB, there are several
controversial reports (Budiyanto et al., 2002; Orimo et al.,
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2006). Therefore, we assessed accumulation of 8-oxoG by
single NB-UVB exposure using each Ogg1 genotype mice as
well. Immunohistochemically no significant difference in
intensity of 8-oxoG staining was observed after NB-UVB
exposure irrespective of Ogg1 genotype (Figure 3c), indica-
ting that very little amount of 8-oxoG is produced by
NB-UVB. Figure 3c also showed that much less amount of
8-oxoG was formed after 1 MED by NB-UVB in comparison
to that by BB-UVB, which is consistent with those reported by
Orimo et al. (2006).
As for tumor induction, wild-type mice irradiated with NB-
UVB began to develop tumors 3 weeks earlier than with BB-
UVB, and 100% incidence was at 41 weeks, 3 weeks earlier
than with BB-UVB (Figure 4). This shows that NB-UVB also
promotes the onset of tumor development earlier than BB-UVB,
which is compatible with the report by Flindt-Hansen et al.
In conclusion, we demonstrate that CPD formation in
epidermal cells, rather than formation of (6-4) photoproduct
or 8-oxoG, is closely related to the carcinogenic activity of
NB-UVB. The most important factor to be considered is the
balance between the efficiency and carcinogenicity of NB-
UVB treatment required for treating several skin diseases
(Gibbs et al., 1995; Weischer et al., 2004). If the tumor
incidence is plotted to the total accumulative dose, BB-UVB
induces skin tumors by smaller dose (Supplementary data).
However, we usually use higher dose in treating with NB-
UVB when we decide the initial therapeutic dose being
standardized by MED. There are reports that the effectiveness
of NB-UVB treatment has an advantage over BB-UVB
treatment for psoriasis (Coven et al., 1997, Walters et al.,
1999). NB-UVB phototherapy has to be considered in the
balance between the higher carcinogenic characteristics and
the higher therapeutic benefits. Thus, it will be ideal if we will
be able to determine the optimum dose and wavelength to
obtain the effective immunomodulation without carcinogeni-
city.
MATERIALS AND METHODS
Mice
Albino hairless albino mice (Balb/cA Kud-hr) were used for the
comparative study of NB-UVB and BB-UVB continuous irradiation.
C57BL/6J Ogg1 knockout mice (Sakumi et al., 2003), together with
wild-type mice, were used to study skin tumor production following
NB-UVB exposure. We inbred Ogg1 heterozygous mice (C57BL/6J,
N¼ 12) and genotype was determined as described previously
(Sakumi et al., 2003). These mice were also used for DNA damage
detection by UVB exposure using immunohistochemical study. Mice
aged 12–15 weeks were selected and divided into groups of 10 mice
each corresponding to each type of UVB source and Ogg1 genotype,
in wild-type and Ogg1 knockout mice. The mice were housed under
special pathogen-free conditions, and all animal experiments were
conducted according to the Guideline for Animal Experimentation at
Kobe University School of Medicine.
NB-UVB and BB-UVB irradiation
Banks of six TL 20W/01RS and TL 20W/12RS fluorescent lamps
(Philips, Eindhoven, Holland) were used to irradiate the mice with
NB-UVB or BB-UVB, respectively. TL 20W/01RS lamps emit in a
narrow peak around 311 nm exclusively. TL 20W/12RS lamps emit a
continuous spectrum from 275 to 390 nm, with a peak emission at
313 nm; approximately 65% of that radiation is within the UVB
wavelength range (Figure 1a). The irradiance was 7.6 J/m2/second for
TL 20W/01RS lamps and 3.8 J/m2/second for TL 20W/12RS lamps at
a distance of 40 cm, as measured by an IL1400A radiometer/
photometer (International Light Inc., Peabody, MA), or an UVR-305/
365D digital radiometer (Tokyo Kogaku Kikai KK, Tokyo, Japan),
respectively. For skin tumor production, the mice were placed 40 cm
below the bank of lamps and were irradiated three times per week
over 30 weeks (for albino hairless mice) and over 40 weeks (for
C57BL/6J mice, after shaving their backs). For the TL 20W/01RS
lamps, exposures of 370 or 850 mJ/cm2 are the approximate sub-
MEDs for albino hairless mice and for C57BL/6J mice, respectively.
Exposures with 170 or 250 mJ/cm2 are the approximate MEDs for
albino hairless mice and for C57BL/6J mice, respectively, for the TL
20W/12RS lamp (Figure 1b). For immunohistochemical detection of
CPD, (6-4) photoproduct and 8-oxoG after UVB irradiation, mice
aged 12 weeks were irradiated with the same doses of MED
irradiance corresponding to each type of UVB source.
Immunohistochemistry
For detection of CPD or (6-4) photoproduct, skin specimens were
obtained at 3 minutes, 3 and 72 hours after NB-UVB or BB-UVB
irradiation. For detection of 8-oxoG, skin specimens were taken at 3
and 72 hours after NB-UVB or BB-UVB irradiation. Skin specimens
were subjected to immunohistochemical staining as described
previously (Kunisada et al., 2005) using primary mouse monoclonal
antibodies against CPD (TDM-2), (6-4) photoproduct (64M-1)
(Mizuno et al. 1991), or 8-oxoG (N45.1) (Hattori et al., 1996).
Specimens were observed using an Olympus FluoView confocal
laser scanning microscope (Olympus Co. Ltd., Nagano, Japan).
Observation and measurement of cumulative tumor incidence
After the chronic UVB exposure, we observed tumor formation until
all mice developed skin tumors. The numbers of tumors with
diameters larger than 2 mm in diameter were counted. Tumors less
than 2 mm in diameter, or those that regressed, were not counted.
The numbers of tumors on mice that died during the experiment
were not included. All mice were killed at the final observation and
all skin tumors were excised and examined histologically with
hematoxylin and eosin staining. In addition, all mice including mice
that died during the experiment were subjected to autopsy to
confirm whether they had internal spontaneous tumors macrosco-
pically.
Histological analysis
Tumors examined histologically were classified as malignant or
benign. Malignant tumors were classified as squamous cell carcino-
mas (tumors with atypical epithelial differentiation) or sarcomas
(tumors with atypical mesenchymal differentiation), whereas benign
tumors were classified as papillomas (tumors with papillomatous
growth of epidermal cells without atypicality) or cysts.
Statistical analysis
Results are expressed as the mean7SD. Statistical differences were
determined using an un-paired t-test for mean number of tumors/
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mouse and the w2 test for malignant tumor rate; Po0.05 is
considered to be statistically significant.
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Figure S1. Difference of tumor induction following NB-UVB or BB-UVB with
Ogg1 genotype according to total dose of irradiation.
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